Recently our profession has been rocked by the senseless deaths of several dozen patients, with hundreds more sickened by contaminated steroid injections. The incident is still under investigation, but it will certainly alter the regulatory landscape for the future. Such a devastating incident underscores the need for advancing regulatory sciences and a strong collaborative relationship between academia, government, and industry.
The PDA Journal is right at such a confluence, and we will continue to provide scientific leadership by publishing the highest quality articles. In this context, we are delighted to welcome Dr. Beth Junker as the newest member of our editorial team. Dr. Junker is a highly accomplished industry professional. Her experience with a broad array of pharmaceutical product development and regulatory aspects makes her an ideal complement to the current team. We eagerly look forward to her insights and contributions as we continue to move the Journal forward in its mission of connecting people, science, and regulation. Details of Beth's many accomplishments are in her biographical sketch on the editorial page (http://journal.pda.org/site/misc/edboard.xhtml). Please join us in welcoming her, and start sending her your articles!
- © PDA, Inc. 2013
